September 03, 2020
Aurobindo Pharma USA Inc. is recalling 5748 bottles of sulfamethoxazole and trimethoprim tablets after customers reported metal wire in the tablets, according to the September 2, 2020, US Food and Drug Administration (FDA) Enforcement Report.
The recall affects sulfamethoxazole and trimethoprim tablets, 800 mg/160 mg, 500-tablet bottles (NDC 65862-420-05) from lots STSD19109-A (Exp. 5/31/22), SP1D19083AA3 (Exp. 8/31/22), and SP1D19084AA3 (Exp. 8/31/22). The bottles were distributed throughout the United States.
Aurobindo Pharma USA initiated the recall August 10, 2020. On August 21, 2020, the FDA designated the recall Class II. Under Class II recalls, use of the product could cause temporary or medically reversible adverse health consequences, or a remote possibility of serious harm.
Available with a prescription, sulfamethoxazole and trimethoprim is a combination antibiotic medication used to treat or prevent infections.